Dr. Hollander is the Esther and Joseph Klingenstein Professor and Chair of Psychiatry at the Mount Sinai School of Medicine in New York City. He is also Director of the Seaver and Greater New York Autism Center of Excellence, also at the Mount Sinai School of Medicine.
Dr. Hollander received his B.A. from Brandeis University (1978), and his M.D. from SUNY Downstate Medical College, Brooklyn (1982). He completed his internship in Internal Medicine at Mt. Sinai Hospital (1983), residency and chief resident in psychiatry at Mt Sinai School of Medicine (1986), and his NIMH research fellowship at Columbia University College of Physicians and Surgeons (1988). He was appointed Associate Professor of Psychiatry at Columbia University College of Physicians and Surgeons in 1992. He joined the faculty of Mount Sinai School of Medicine as an Associate Professor of Psychiatry in 1993, and rose through the academic ranks at MSSM and was appointed Professor in 1996.
Dr. Hollander is the principal investigator for a number of current federal grants, including the NIH Greater New York Autism Center of Excellence, the NIMH Research Training Grant in Psychopharmacology and Outcomes Research, and an FDA funded multicenter treatment trial of pediatric body dysmorphic disorder. He is the principal investigator of the autism Clinical Trials Network, and Chair of the eight center NIH STAART Autism Steering Committee. He is involved in research on the neuropharmacology, neuropsychiatry, functional imaging, and treatment of obsessive-compulsive disorder, impulsive/aggressive personality disorders, obsessive-compulsive-related disorders such as body dysmorphic disorder, pathological gambling, and autism. Dr. Hollander has spearheaded affiliation agreements between Mount Sinai School of Medicine and service providers such as the YAI/NIPD Network. He serves as Chair of the DSM-V Research Planning Agenda for Obsessive Compulsive Behavior Spectrum Disorders.
Dr. Hollander has received a Research Scientist Development Award from the National Institute of Mental health to investigate the psychobiology of obsessive-compulsive and related disorders. He has received orphan drug grants from the Food and Drug Administration to study new treatments for body dysmorphic disorder, child/adolescent autism, and adult autism, and a grant from the National Institute of Drug Abuse for a study on the neurobiology of pathological gambling. He has received several grants from the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke, to develop treatments for borderline personality disorder, adolescent body dysmorphic disorder, and autism. Dr. Hollander has received two national research awards from the American Psychiatric Association and a Distinguished Investigator Award from the National Alliance for Research in Schizophrenia and Depression.
During his career, Dr. Hollander has published more than 450 scientific reports in the psychiatric field. He has edited 19 books, including Autism Spectrum Disorder (2003), the American Psychiatric Publishing Textbook of Anxiety Disorders (2002), and The Clinical Manual of Impulse Control Disorders (2006). Dr. Hollander also serves as a reviewer for 8 medical journals.
Dr. Hollander is listed in NY Magazine’s “Best Doctors”, and “Best Doctors in America”. He has made frequent media appearances on the Today Show and Dateline NBC and has had interviews in People Magazine and the New York Times. He is co-author of a book with Marc Summers, Everything In Its Place: My Trials and Triumphs with Obsessive Compulsive Disorder (Penguin Putnam, 1999) and co-authored with Nick Bakalar, Coping with Social Anxiety: The Definitive Guide to Effective Treatment Options (Henry Holt and Company, 2005).
